The interbody fusion cage market is expected to grow through 2025, according to a MarketReserachNest report.
Five key trends:
1. The increasing geriatric population and high rates of spinal injuries and sports injuries are a factor in market growth. There is also an increased consumer awareness about direct nerve decompression and spinal reconstruction.
2. There are strict rules and regulations around interbody fusion cages as well as a high cost associated with spinal fusion, which could dampen growth. However, report authors noted that "introduction of novel interbody fusion cages provided with new compatible materials is likely to create more opportunities in the market."
3. The thoracoloumbar segment has the biggest market share, and anterior surgery was most common in 2017.
4. North America is the geographic market leader for the interbody fusion cage market by revenue, with Europe coming in second. China, South Korea, Brazil and India are expected to grow rapidly over the next half-decade.
5. Benvenue Medical, Aurora Spine, Ulrich Medical, NuVasive, B.Braun Melsungen, Orthofix, Medtronic, Prodorth, Zimmer Biomet and Johnson & Johnson are the major players in the market.